Hydrochloric Acid → N-(3-chloro-4-(piperazin-1-yl)phenyl)picolinamide
Reaction equation
Cl.O1CCOCC1.[Cl:8][C:9]1[CH:14]=[C:13]([NH:15][C:16](=[O:23])[C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][N:18]=2)[CH:12]=[CH:11][C:10]=1[N:24]1[CH2:29][CH2:28][N:27](C(OC(C)(C)C)=O)[CH2:26][CH2:25]1>C(Cl)Cl>[Cl:8][C:9]1[CH:14]=[C:13]([NH:15][C:16](=[O:23])[C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][N:18]=2)[CH:12]=[CH:11][C:10]=1[N:24]1[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]1Participants
5
Procedure
According to Scheme 5 Step 4: HCl 4 M in dioxane (12.3 mmol, 3.07 mL) was added to a solution of tert-butyl 4-(2-chloro-4-(picolinamido)phenyl)piperazine-1-carboxylate (2.46 mmol, 1.02 g) in DCM (10 mL). The reaction mixture was stirred at room temperature overnight. After evaporation, DCM was added and then a NaOH 1 M solution. The aqueous phase was extracted with DCM. The organic phase was washed with brine, was dried over MgSO4, was filtered and was concentrated under reduced pressure. The crude product was purified by flash chromatography over silica gel using cyclohexane/AcOEt (60:40) as eluent to afford N-(3-chloro-4-(piperazin-1-yl)phenyl)picolinamide (0.97 mmol, 308 mg, 40%) as an orange solid.
Workup
- customAfter evaporation, DCM
- additionwas added
- extractionThe aqueous phase was extracted with DCM
- washThe organic phase was washed with brine
- dry with materialwas dried over MgSO4
- filtrationwas filtered
- concentrationwas concentrated under reduced pressure
- customThe crude product was purified by flash chromatography over silica gel
Sources & evidence
- ORD record
- ord-85b89279c2bd4d0dafccb9dbb4150929
- Source dataset
- uspto-grants-2013_09
- Patent number
- US08524726B2
Reaction notes
Loading…